Author: Philip M. Parker
Manufacturer: ICON Group International, Inc.
This study covers the latent demand outlook for sulfonamide pharmaceuticals excluding sulfa-antibiotic
combinations across the states, union territories and cities of India. Latent demand (in millions of U.S. dollars), or potential industry earnings (P.I.E.) estimates are given across some 3, 800 cities in India. For each city in question, the percent share the city is of it's state or union territory and of India as a whole is reported. These comparative benchmarks allow the
reader to quickly gauge a city vis-